Treatment of Musculoskeletal Diseases - France
France- In France, the Treatment of Musculoskeletal Diseases market is anticipated to achieve a revenue of US$4.29bn in 2024.
- It is projected to display an annual growth rate (CAGR 2024-2029) of 1.50%, leading to a market volume of US$4.62bn by 2029.
- When compared globally, United States is expected to generate the highest revenue in this market, reaching US$60.79bn in 2024.
- France has seen a rise in the use of non-invasive treatments for musculoskeletal diseases, such as physical therapy and acupuncture.
- Key regions:
- Europe,
- Canada,
- United States,
- Germany,
- India
Definition:
Treatments of Musculoskeletal Diseases refer to medical care and/or surgical procedures provided to patients who require hospitalization due to severe or complex musculoskeletal conditions, such as fractures, joint replacements, or degenerative diseases. The causes of these diseases range from senile decay and genetic inheritance to injuries. The goal of inpatient musculoskeletal care is to promote healing, restore function, and provide strategies for pain management of the affected area.
Additional information:
The Treatments of Musculoskeletal Diseases market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Diagnostic tests
- Surgical procedures, such as joint replacements, spinal surgeries, and orthopedic surgeries
- Pain management and control
- Physical therapy
- Monitoring and management of post-surgical complications
Out-Of-Scope
- Outpatient diagnostic tests and procedures
- Home health care services and support
